Status:
COMPLETED
Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will evaluate the effectiveness of a modified directly observed therapy program in increasing antiretroviral therapy adherence in poor, HIV-infected residents of urban communities.
Detailed Description
Antiretroviral drug therapy (ART) is a type of medication treatment for HIV that impairs the virus's ability to multiply. When used properly, it has been shown to be successful in reducing HIV-related...
Eligibility Criteria
Inclusion
- HIV infected
- Severely immunosuppressed (HIV viral load of greater than 400 copies/ml)
- Does not consistently take prescribed ARV
- Currently prescribed HIV medications or prescribed to start taking HIV medications
Exclusion
- Currently participating in any other adherence program or intervention study
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00339092
Start Date
January 1 2003
End Date
April 1 2008
Last Update
April 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Market Street Study Site
San Francisco, California, United States, 94102